Table 2.
BP Group, mm Hg | BP Treatment | No. Events/No. at Risk | Person‐Years | Crude Event Rates (95% CI)a | HR (95% CI)b | P Value | HR (95% CI)c | P Value | |
---|---|---|---|---|---|---|---|---|---|
1 | <120/80 | No | 65/909 | 9997 | 0.65 (0.51–0.83) | 1 | 1 | ||
2 | ≥120/80 to <140/90 | No | 116/970 | 10 170 | 1.14 (0.95–1.37) | 1.35 (1.00–1.84) | 0.054 | 1.36 (1.00–1.85) | 0.053 |
3 | <140/90 | Yes | 80/393 | 3842 | 2.08 (1.67–2.59) | 1.92 (1.36–2.71) | 0.0002 | 1.60 (1.08–2.38) | 0.020 |
4 | ≥140/90 | No | 88/413 | 4091 | 2.15 (1.75–2.64) | 1.94 (1.39–2.71) | 0.0001 | 1.97 (1.39–2.79) | 0.0001 |
5 | ≥140/90 | Yes | 100/339 | 3125 | 3.20 (2.64–3.88) | 2.44 (1.74–3.43) | <0.0001 | 1.96 (1.30–2.98) | 0.0015 |
Total | 449/3024 | 31 225 | 1.44 (1.31–1.58) |
BP indicates blood pressure; HDL, high‐density lipoprotein; HR, hazard ratio.
Events per 100 person‐years.
HRs are adjusted for age, sex, total and HDL cholesterol, intake of lipid‐lowering medication, smoking, diabetes, aspirin use, and estimated glomerular filtration rate.
HRs are adjusted for age, sex, total and HDL cholesterol, intake of lipid‐lowering medication, smoking, diabetes, aspirin use, estimated glomerular filtration rate, duration of hypertension, and duration of hypertension treatment.